| Ticker Details |
Medtronic plc
Medtronic PLC is a medical technology company. It is primarily manufactures and sells device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$120.46B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.68 | 1.00%
|
| Avg Daily Range (30 D): |
$0.91 | 1.02%
|
| Avg Daily Range (90 D): |
$1.07 | 1.31%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.22M |
| Avg Daily Volume (30 D): |
6.06M |
| Avg Daily Volume (90 D): |
7.23M |
| Trade Size |
| Avg Trade Size (Sh.): |
137 |
| Avg Trade Size (Sh.) (30 D): |
68 |
| Avg Trade Size (Sh.) (90 D): |
74 |
| Institutional Trades |
| Total Institutional Trades: |
114,075 |
| Avg Institutional Trade: |
$4.97M |
| Avg Institutional Trade (30 D): |
$13.64M |
| Avg Institutional Trade (90 D): |
$11.35M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
19 |
| Market Closing Trades |
| Avg Closing Trade: |
$49.59M |
| Avg Closing Trade (30 D): |
$112.02M |
| Avg Closing Trade (90 D): |
$128.56M |
| Avg Closing Volume: |
599.72K |
|
|
| Financials |
| |
TTM |
Q1 2027 |
Q4 2026 |
|
Basic EPS
|
|
$1.15
|
|
|
Diluted EPS
|
|
$1.14
|
|
|
Revenue
|
|
$9.76B
|
|
|
Gross Profit
|
|
$6.34B
|
|
|
Net Income / Loss
|
|
$1.48B
|
|
|
Operating Income / Loss
|
|
$1.76B
|
|
|
Cost of Revenue
|
|
$3.42B
|
|
|
Net Cash Flow
|
|
$-258M
|
|
|
PE Ratio
|
|
|
|
|
|
|
